Pharsight

Drugs that contain Finafloxacin

1. Xtoro patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9119859 MERLION PHARMS GMBH Methods for treating otic infections
Jul, 2030

(6 years from now)

US9993483 MERLION PHARMS GMBH Compositions and methods for treating ophthalmic, octic, or nasal infections
Jul, 2030

(6 years from now)

US8536167 MERLION PHARMS GMBH Methods for treating ophthalmic, otic, or nasal infections
Aug, 2031

(7 years from now)

US9504691 MERLION PHARMS GMBH Finafloxacin suspension compositions
Nov, 2033

(9 years from now)

Market Authorisation Date: 17 December, 2014

Treatment: Treatment of acute otitis externa

Dosage: SUSPENSION/DROPS;OTIC

More Information on Dosage

XTORO family patents

Family Patents